Search

PerkinElmer Inc

Closed

SectorHealthcare

0

Overview

Share price change

24h

Current

Min

Max

Key metrics

By Trading Economics

Income

13M

53M

Sales

19M

730M

P/E

Sector Avg

75.05

51.78

EPS

1.37

Dividend yield

0.18

Profit margin

7.329

Employees

11,000

EBITDA

8.8M

189M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+4.65% upside

Dividends

By Acuity

Dividend yield

Sector Avg

0.18%

1.96%

Next Earnings

1 lut 2027

Next Dividend date

13 lis 2026

Next Ex Dividend date

22 sty 2027

Market Stats

By TradingEconomics

Market Cap

4.1B

17B

Previous open

0

Previous close

0

PerkinElmer Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

4 lis 2026, 21:05 UTC

News
Correlated Moves

Revvity, Inc. declines as JP Morgan, Barclays, and RBC Capital raise price targets to $160, $175, and $172, respectively, amid broader market conditions.

3 lis 2026, 23:06 UTC

Revvity, Inc. shares traded modestly lower in after-market hours on Tuesday, remaining above its 20-day moving average and near the upper end of its one-month range.

2 lis 2026, 23:31 UTC

In after-market trading, Revvity, Inc. has gained ground, recovering from earlier weakness to reach a peak just before the latest observation.

30 paź 2026, 21:51 UTC

News

Revvity, Inc. declared a quarterly dividend of $0.07 per share, payable on February 12, 2027, to shareholders of record as of January 22, 2027.

29 paź 2026, 20:07 UTC

Revvity, Inc. shares are advancing, marking nine consecutive days of higher closes and peaking significantly above Wednesday's close.

28 paź 2026, 20:06 UTC

Correlated Moves

Revvity, Inc. shares are advancing, continuing an upward trend since Tuesday, despite earlier pulling back from a session high, remaining above its 20-day moving average.

26 paź 2026, 19:16 UTC

Revvity Inc shares are advancing, continuing a trend of modest gains since Friday's close, despite an earlier pullback from a session high.

23 paź 2026, 20:13 UTC

Revvity Inc shares are trading modestly higher in after-market hours, continuing a trend of five consecutive sessions finishing higher.

22 paź 2026, 21:41 UTC

Revvity Inc shares have declined in after-market trading, reaching their lowest point of the day after moving from a slight loss post-close.

21 paź 2026, 20:07 UTC

Correlated Moves

Revvity Inc shares are advancing, continuing an upward trend since Tuesday, while Charles River Laboratories is sharply higher with increased trading activity and volume.

20 paź 2026, 20:02 UTC

News

Revvity Inc. launches its AI-first Signals LabGistics solution to streamline scientific workflows in pharma and biotech, with positive outlook from Citrini Research.

19 paź 2026, 19:36 UTC

Correlated Moves

Revvity Inc shares are declining, facing speculation around Thermo Fisher Scientific Inc's upcoming earnings report, despite earlier reaching a session high.

16 paź 2026, 21:02 UTC

Revvity Inc's shares are declining in after-market trading, hitting their lowest level since Friday's close amid ongoing price weakness.

15 paź 2026, 23:46 UTC

Revvity Inc's shares declined modestly in after-market trading, following earlier gains, and remain near the upper end of their one-month range.

14 paź 2026, 23:46 UTC

Revvity Inc shares are trading modestly lower in after-market hours, continuing a decline that began after Wednesday's close.

13 paź 2026, 20:13 UTC

Revvity Inc shares are trading modestly lower in after-market hours, continuing a downward trend since Tuesday's close amid unusual weakness during the session.

12 paź 2026, 19:51 UTC

Revvity Inc shares are advancing, continuing a higher trend since Friday's close, despite currently trading lower in today's session.

8 paź 2026, 20:06 UTC

Revvity Inc shares are declining, having pulled back from earlier gains amid a broader market trend lower since Wednesday's close.

7 paź 2026, 19:25 UTC

News

Barclays raised Revvity Inc's price target to $160.00 from $115.00, maintaining an Equal-weight rating, as the stock trades modestly higher.

6 paź 2026, 22:41 UTC

News

Revvity Inc shares declined in after-market trading despite an Outperform rating from William Blair, closing at their lowest point since Tuesday.

5 paź 2026, 19:21 UTC

Correlated Moves

Revvity Inc is advancing, likely influenced by a significant rise in shares of Charles River Laboratories, reaching its best cumulative return since Friday's close.

2 paź 2026, 19:45 UTC

News

Revvity Inc. will release Q3 2026 financial results on November 3, 2026, contributing to the stock's upward movement today, despite a slight retracement.

1 paź 2026, 20:03 UTC

Revvity Inc shares fell sharply from an early peak, currently trading near their lowest point of the day despite being above the 20-day moving average.

30 wrz 2026, 21:02 UTC

Revvity Inc is trading modestly higher in after-market hours, significantly above its 20-day moving average and near the upper end of its one-month range.

29 wrz 2026, 19:36 UTC

Revvity Inc is trading higher, reaching a peak return since Monday's close and maintaining a position above its 20-day moving average.

28 wrz 2026, 20:20 UTC

Revvity Inc's shares are trading modestly lower in after-market hours, shifting from a slight gain to a loss since Monday's close.

25 wrz 2026, 20:01 UTC

Revvity Inc shares fell sharply, pulling back from earlier gains and currently trading below Thursday's close despite being above its 20-day moving average.

24 wrz 2026, 23:11 UTC

Revvity Inc has advanced modestly in after-market trading, remaining significantly above its 20-day moving average and showing notable gains over the past month.

23 wrz 2026, 20:07 UTC

Revvity Inc shares fell sharply, settling below Tuesday's close after an early peak, though remaining above the 20-day moving average.

22 wrz 2026, 19:31 UTC

Revvity Inc shares fell sharply after briefly gaining earlier, but remain above their 20-day moving average and near the upper end of their one-month range.

Peer Comparison

Price change

PerkinElmer Inc Forecast

Price Target

By TipRanks

4.65% upside

12 Months Forecast

Average 166.846 USD  4.65%

High 190 USD

Low 120 USD

Based on 15 Wall Street analysts offering 12 month price targets forPerkinElmer Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

15 ratings

6

Buy

9

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About PerkinElmer Inc

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
help-icon Live chat